Meeting Overview - The fourth session of the Supervisory Board of Guangzhou Anbiping Pharmaceutical Technology Co., Ltd. was held on August 21, 2025, combining in-person and remote participation [1] - The meeting was convened by Chairwoman Jin Xinyu, with all three supervisors participating in the voting [1] Resolutions Passed - The Supervisory Board approved the "2025 Half-Year Report" and its summary, confirming that the report accurately reflects the company's financial status and operational results for the reporting period [1][2] - The board also approved the "Special Report on the Storage and Actual Use of Raised Funds for the First Half of 2025," which disclosed the management of raised funds without any misappropriation or harm to shareholder interests [2] - Approval was granted for the use of up to 140 million yuan of temporarily idle raised funds for cash management, ensuring compliance with relevant regulations and not affecting the normal implementation of investment projects [3] - The board agreed to temporarily adjust the use of idle spaces from fundraising investment projects for external leasing, which aligns with the company's operational stability [4]

Core Points - The company has completed the fundraising project "Application Development Project Based on Tumor Companion Diagnosis Technology Platform" and will use the remaining funds of 14,800 yuan to supplement working capital [1][5] - The total amount raised from the initial public offering was 713.27 million yuan, with a net amount of 639.95 million yuan after deducting issuance costs [1][2] - The project had a planned investment of 496.65 million yuan, with an actual investment of 367.55 million yuan, resulting in a surplus of 1.48 million yuan [2][3] Fundraising Overview - The company issued 23.34 million shares at a price of 30.56 yuan per share, raising a total of 713.27 million yuan [1][2] - The funds were stored in a dedicated account and managed under a regulatory agreement with the underwriter and the bank [2] Project Details - The project aimed to develop applications based on tumor companion diagnosis technology, with a total planned investment of 496.65 million yuan [2][3] - The actual investment was 367.55 million yuan, with a remaining surplus of 1.48 million yuan [3] Approval Process - The completion of the fundraising project and the use of surplus funds do not require board approval or explicit consent from the underwriter, as per the regulations [5]

证券代码：605088 证券简称：冠盛股份 公告编号：2025-085 温州市冠盛汽车零部件集团股份有限公司关于 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据中国证券监督管理委员会《上市公司募集资金监管规则》（证监会公告〔2025〕10 号）和上海证券交易所印发的《上海证券交易所上市公司自律监管指引第 1 号——规范运作 （2025 年 5 月修订）》（上证发〔2025〕68 号）的规定，将本公司 2025 年半年度募集资金 存放与使用情况专项说明如下。 一、募集资金基本情况 (一)首次公开发行股票 根据中国证券监督管理委员会《关于核准温州市冠盛汽车零部件集团股份有限公司首次 公开发行股票的批复》(证监许可〔2020〕1091 号文核准)，并经上海证券交易所同意，本 公司由主承销商国金证券股份有限公司采用余额包销方式，向社会公众公开发行人民币普通 股（A 股）股票 40,000,000 股，发行价为每股人民币 15.57 元，共计募集资金 622,800,000.00 元，坐扣承销和保荐费用（不含增值税）45,0 ...

Summary of Key Points Core Viewpoint The report outlines the fundraising status and actual usage of funds by Tianxiaxiu Digital Technology (Group) Co., Ltd. for the first half of 2025, highlighting the management of raised funds, changes in investment projects, and compliance with regulatory requirements. Fundraising Basic Situation - The company raised a total of RMB 2,071,879,874.54 after deducting various fees from the gross amount of RMB 2,073,699,994.66 [1] - As of June 30, 2025, the company has utilized RMB 892,246,100.00 of the raised funds, leaving a balance of RMB 1,239,435,900.00 [1] Fundraising Management Situation - The company appointed CITIC Securities as the sponsor for the 2022 convertible bond issuance, taking over from Huatai United Securities [2] - The board approved changes to the investment projects, shifting from "New Media Big Data Platform Construction" and "WEIQ New Media Marketing Cloud Platform Upgrade" to "Content Marketing Ecosystem Upgrade" and "Innovative Technology Module Upgrade" [2] Fundraising Usage and Compliance - The company has opened 13 fundraising accounts, with six accounts closed, and has adhered to regulations for the management and usage of raised funds [3] - As of June 30, 2025, the company has not engaged in any pre-investment or replacement of funds for investment projects [5] - The company temporarily used RMB 70,000,000 of idle funds to supplement working capital, with a usage period not exceeding 12 months [5] Cash Management of Idle Funds - The company has utilized idle funds for cash management, achieving a total investment income of RMB 3,647,400.00, with RMB 783,600.00 earned during the reporting period [6] - All cash management products are principal-protected, and no idle funds were used for investments in related products as of June 30, 2025 [6] Changes in Fundraising Investment Projects - The board meetings held on November 19, 2024, and December 5, 2024, approved the change in fundraising investment projects, with the sponsor agreeing to the changes [4][7] - The total amount of funds raised is RMB 207,187,990.00, with 58.10% of the funds allocated to changed projects [7]

证券代码：600080 股票简称： 金花股份 编号：临 2025-037 金花企业（集团）股份有限公司 关于公司 2025 年半年度募集资金存放与实际使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并 对其内容的真实性、准确性和完整性承担个别及连带责任。 一、募集资金基本情况 （一）实际募集资金金额、资金到账时间 经中国证监会《关于核准金花企业（集团）股份有限公司非公开发行股票的批复》 （证监许可[2017]1648 号）核准，金花企业（集团）股份有限公司（以下简称"公司"） 发行股票 67,974,413 股（A 股），发行价格为人民币 9.38 元/股，本次发行募集资金总 额为人民币 637,599,993.94 元，扣除各项发行费用后，实际募集资金净额为人民币 进行了审验，并于 2018 年 3 月 22 日出具的《金花企业（集团）股份有限公司验资报告》 (瑞华验字[2018]61060001 号)审验确认。 （二）截止 2025 年 6 月 30 日，募集资金使用情况及余额： 项目 金额（元） 募集资金总额 637,599,993.94 减：支付的发 ...

Core Points - The document outlines the fundraising management system of Falan Tech Heavy Industry Co., Ltd, aiming to standardize the management of raised funds, improve usage efficiency, and protect investor interests [1][2][3] Fundraising Overview - Fundraising refers to the capital raised through public offerings of securities, including IPOs, rights issues, and convertible bonds, excluding funds raised for equity incentive plans [1] - Upon receipt of funds, the company must promptly conduct verification procedures and may open dedicated accounts for large amounts, ensuring funds for the same project are stored in the same account [2][3] Fund Storage Management - Funds must be stored in dedicated accounts approved by the board and cannot be mixed with other funds or used for non-designated purposes [3][4] - A tripartite supervision agreement must be signed with the sponsor or independent financial advisor and the commercial bank within one month of fund receipt [4][5] Fund Usage Management - Funds should primarily be used for main business operations and cannot be used for financial investments or to benefit related parties [6][7] - Any changes to the investment plan must be disclosed, and if significant issues arise, the company must announce them promptly [7][8] Fund Usage Supervision - The finance department must maintain a detailed ledger of fund usage, and internal audits should occur quarterly [15][16] - The board must report any discrepancies in fund usage and ensure compliance with the established management system [15][16] Changes in Fund Direction - Changes to the investment projects must be approved by the board and disclosed, ensuring that new projects align with the company's main business [9][10] - If funds are to be redirected for new projects, a feasibility analysis must be conducted, and the board must ensure that the changes enhance competitiveness and mitigate risks [10][11] Reporting and Disclosure - The company must disclose the status of fund usage in annual and semi-annual reports, including any changes in investment plans and the rationale behind them [16][17] - Any significant changes in fund management or usage must be reported to the stock exchange within two trading days [17][18]

金花企业（集团）股份有限公司 募集资金管理办法 第一章 总 则 第四条 公司应当审慎使用募集资金，保证募集资金的使用与发行申请文件 的承诺相一致，不得随意改变募集资金的投向。 公司应当真实、准确、完整地披露募集资金的实际使用情况。出现严重影响 募集资金投资计划正常进行的情形时，应当及时公告。 募集资金投资项目（以下简称"募投项目"）通过公司的子公司或者公司控 制的其他企业实施的，公司应当确保该子公司或者受控制的其他企业遵守本办 法。 第五条 公司的董事、高级管理人员应当勤勉尽责，督促公司规范使用募集 资金，自觉维护公司募集资金安全，不得参与、协助或纵容公司擅自或变相改变 募集资金用途。 第一条 为规范金花企业（集团）股份有限公司（以下简称"公司"）募集 资金的管理和运用，提高募集资金的使用效率，防范资金使用风险，保护投资者 的合法利益，根据《中华人民共和国公司法》、《中华人民共和国证券法》、《上 市公司证券发行注册管理办法》、《首次公开发行股票注册管理办法》、《上市 公司募集资金监管规则》、《上海证券交易所上市公司自律监管指引第1号—— 规范运作》、《上海证券交易所股票上市规则》等法律、法规、规范性文件以及 ...

Core Points - The company, Tianxiaxiu Digital Technology (Group) Co., Ltd., is utilizing its own funds to pay for part of the investment projects and will replace these with raised funds later [1][5] - The total amount raised from the non-public offering of shares was approximately RMB 2.07 billion, with a net amount of RMB 2,071,879,874.54 [1][2] - The company has changed its investment projects from "New Media Commercial Big Data Platform Construction Project" and "WEIQ New Media Marketing Cloud Platform Upgrade Project" to "Content Marketing Ecosystem Upgrade Project" and "Innovative Technology Module Upgrade Project" [2][3] Fundraising and Investment Projects - The total investment amount for the original projects was RMB 251,510.20 million, with RMB 207,187.99 million allocated from the raised funds [2] - The new projects have a total investment amount of RMB 131,957.04 million, with RMB 126,239.21 million planned to be funded from the raised funds [3] Reasons for Using Own Funds - The company faced operational challenges in paying salaries and other expenses directly from the raised funds due to banking regulations [5][6] - To ensure the smooth implementation of investment projects and improve the efficiency of fund usage, the company opted to use its own funds initially and will replace them with raised funds within six months [5][6] Decision-Making Process - The board of directors and the supervisory board approved the use of own funds for the investment projects during meetings held on August 21, 2025 [6][7] - The approval process followed necessary procedures and ensured that the use of funds would not affect the normal implementation of the investment projects or harm shareholder interests [7] Sponsor's Verification Opinion - The sponsor, CITIC Securities, confirmed that the company's actions regarding the use of its own funds and subsequent replacement with raised funds complied with relevant laws and regulations [7][8]

证券代码：688188 证券简称：柏楚电子 公告编号：2025-030 上海柏楚电子科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 募集资金基本情况 （一） 募集资金金额及资金到位时间 经中国证券监督管理委员会于 2019 年 7 月 16 日出具《关于同意上海柏楚电 子科技股份有限公司首次公开发行股票注册的批复》（证监许可[2019]1293 号） 同意注册，上海柏楚电子科技股份有限公司（以下简称"公司"或"柏楚电子"） 首次向社会公开发行人民币普通股（A 股）2,500.00 万股，每股面值 1.00 元，每 股 发 行 价 格 68.58 元 ， 募 集 资 金 总 额 1,714,500,000.00 元 ， 扣 除 发 行 费 用 募集资金于 2019 年 8 月 2 日全部到位，立信会计师事务所（特殊普通合伙）对 上述募集资金到位情况进行了审验，并出具了《验资报告》（信会师报字[2019] 第 ZA15319 号）。 根据中国证券监督管理委员会《关于同意上海柏楚电子科技股份有限公司向 特 ...

确成硅化学股份有限公司 募集资金存放与使用情况的专项报告 证券代码：605183 证券简称：确成股份 公告编号：2025-039 确成硅化学股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 确成硅化学股份有限公司（以下简称"公司"）根据中国证券监督管理委员会《上 市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求（2022 年修订）》 （证监会公告〔2022〕15 号）、《上海证券交易所上市公司自律监管指引第 1 号——规 范运作》以及《上海证券交易所上市公司自律监管指南第 1 号——公告格式》的相关规 定，本公司就 2025 年半年度募集资金存放与使用情况作如下专项报告： 一、 募集资金基本情况 根据本公司 2020 年第三届董事会第九次会议决议和修改后的章程规定，以及中国 证券监督管理委员会证监许可[2020]2296 号文《关于核准确成硅化学股份有限公司首次 公开发行股票的批复》，核准公司发行不超过 48,720,375 股新股。本公司向社会公开发 行人民币普通股（A 股）股票 48,72 ...